16/02/2022 Acadia Pharmaceuticals announces the resubmission of pimavanserin for AD psychosis to FDA Science watch
15/02/2022 AC Immune reports interim results from its Phase I/II study of tau AD vaccine Science watch
14/02/2022 Alzheimer Europe is looking to expand its team by recruiting two project officers and an administrative assistant Alzheimer Europe Job opportunities
13/02/2022 IDEAL programme publishes study findings on methods and approaches for enhancing communication with people with dementia Science watch
10/02/2022 Arkuda Therapeutics raises USD64 million in financing to test a new small molecule therapeutic for frontotemporal dementia in 2023 Science watch
10/02/2022 New research points to an important role for our circadian clock in controlling the clearance of damaging proteins in animal models of Alzheimer's disease Science watch
09/02/2022 Scottish Government publishes analysis of excess death statistics, identifying dementia as the most common pre-existing condition in COVID-19 deaths COVID-19 situation
08/02/2022 Alzheimer Europe signs new Operating Grant agreement with EU disability programme Alzheimer Europe EU developments
